Long-term changes in glucose metabolism after gestational diabetes: a double cohort study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gestational diabetes (GDM) has been associated with an elevated risk of type 2 diabetes in women after the pregnancy. Recognition of the factors differentiating the women at highest risk of progression to overt disease from those who remain normoglycemic after gestational diabetes is of key importance for targeted prevention programmes. To this aim, we investigated the incidence and risk factors of prediabetes and type 2 diabetes with a view to the underlying pathophysiological mechanisms in a long-term follow-up of women with a history of gestational diabetes. METHODS: 489 women with GDM and 385 normoglycemic controls attended a follow-up study after pregnancy (mean follow-up time 7.3, SD 5.1 years) in Kuopio, Finland. Glucose tolerance was evaluated with an oral glucose tolerance test, insulin sensitivity by Matsuda insulin sensitivity index (ISI), and insulin secretion by Disposition Index 30 (DI30). RESULTS: GDM increased risk of pre-diabetes and diabetes (HR 3.7, 95% C.I. 2.8-4.7 and HR 40.7, 95% C.I. 5.3-310.1, respectively, after adjustment for confounding factors) and was associated with both increased fasting (P < 0.001) and 2-hour plasma glucose (P < 0.001) during OGTT at the follow-up study. This effect was attenuated when adjusted for Matsuda ISI but abolished after adjustments with DI30 suggesting insulin secretion is the key defect leading to type 2 diabetes after GDM pregnancy. Increase in waist circumference and weight after pregnancy predicted the development of hyperglycemic conditions in women with a history of GDM (P < 0.001, and P = 0.002, respectively). CONCLUSIONS: Pre-diabetic stages after GDM pregnancy are frequent and reflect the progressive risk of type 2 diabetes in long-term follow-up. Hyperglycemia after GDM pregnancy results from beta cell failure and inability to compensate the increased insulin resistance by insulin secretion. Importantly, increase in waist circumference and as well as weight gain during the follow-up is associated with progression to prediabetes and type 2 diabetes in women with a history GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“normalizes, but previous studies have demonstrated that affected women have at least a seven-fold risk of developing type 2 diabetes later in life [4-7].”
ResultGestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 1×
“Insulin resistance is present early in the natural history of type 2 diabetes and marked beta-cell dysfunction is a rather late event [8].”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s43 · Cited by 924
Metzger, B. E. (1991) · Diabetes · doi:10.2337/diab.40.2.s197 · Cited by 481 · cited 1×
“The prevalence of GDM is on the increase and currently affects 2–14% of all pregnancies [1,2], and is associated with markedly elevated risk of both maternal and fetal complications [3].”
BackgroundClausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., Schmidt, L., & Damm, P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0305 · Cited by 453
Research works printed but not linked: 17
- Persson M, Fadl H, Hanson U, Pasupathy D: Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus. Diabetes Care. 2013, 36 (11): 3543-3548. · DOI
- Jarvela IY, Juutinen J, Koskela P, Hartikainen AL, Kulmala P, Knip M, Tapanainen JS: Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care. 2006, 29 (3): 607-612. · DOI · Paper page
- Gupta D, Krueger CB, Lastra G: Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction. Curr Diabetes Rev. 2012, 8 (2): 76-83. · DOI · Paper page
- Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H: Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-based twin study. Diabetologia. 1999, 42 (2): 139-145. · DOI · Paper page
- Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic medicine: a journal of the British Diabetic Association. 2002, 19 (9): 708-723. · DOI · Paper page
- Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M: Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes. 2009, 58 (5): 1212-1221. · DOI · Paper page
- Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS: Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008, 51 (3): 264-270. · DOI · Paper page
- Egeland GM, Meltzer SJ: Following in mother’s footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2010, 27 (3): 257-265. · DOI
- Stage E, Ronneby H, Damm P: Lifestyle change after gestational diabetes. Diabetes Res Clin Pract. 2004, 63 (1): 67-72. · DOI
- Lie ML, Hayes L, Lewis-Barned NJ, May C, White M, Bell R: Preventing type 2 diabetes after gestational diabetes: women’s experiences and implications for diabetes prevention interventions. Diabetic medicine: a journal of the British Diabetic Association. 2013, 30 (8): 986-993. · DOI · Paper page
- Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE, Diabetes Prevention Program Research G: Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008, 93 (12): 4774-4779. · DOI · Paper page
- Megia A, Vendrell J, Gutierrez C, Sabate M, Broch M, Fernandez-Real JM, Simon I: Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008, 158 (2): 173-178. · DOI · Paper page
- Hussain A, Claussen B, Ramachandran A, Williams R: Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract. 2007, 76 (3): 317-326. · DOI · Paper page
- Buchanan TA: Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab. 2001, 86 (3): 989-993. · doi:10.1210/jcem.86.3.7339 · Paper page
- National Institute for Health and Clinical Excellence: Diabetes in Pregnancy: Management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. 2008
- Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol. 2005, 106 (6): 1297-1303. · DOI · Paper page
- Shah BR, Lipscombe LL, Feig DS, Lowe JM: Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG. 2011, 118 (12): 1484-1490. · DOI · Paper page
Cited by
Vounzoulaki, E., Khunti, K., Abner, S. C., Tan, B. K., Davies, M. J., & Gillies, C. L. (2020) · BMJ · doi:10.1136/bmj.m1361 · Cited by 1,150
“White Aberg et al 2002 Albareda et al 2003 Chodick et al 2010 Huopio et al 2014 Linné et al 2002 Madarász et al 2009 Subtotal: I2=0% Non-white Aziz et al 2018 Herath et al 2017 Krishnaveni et al 2007 Lee H et al 2008 Subtotal: I2=78.2% Mixed Daly et al 2018 Lee AJ et al 2007 Minooee et al…”
BackgroundInfluentialHuvinen, E., Eriksson, J. G., Koivusalo, S. B., Grotenfelt, N., Tiitinen, A., Stach-Lempinen, B., & Rönö, K. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1118-y · Cited by 55
Benhalima, K., Lens, K., Bosteels, J., & Chantal, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091431 · Cited by 50
“…1/16 (6.3) Moleda et al. 2013 [25] Universal one-stepscreening Local (Polish) ** WHO OGTT 13/199 (6.5) 0/50 (0.0) WHO OGTT 73/199 (36.7) 6/50 (12.0) Huopio et al. 2014 [17] Universal one-stepscreening Local (Finnish) *** ADA OGTT 28/489 (5.7) 1/385 (0.3) ADA OGTT 233/489 (47.6) 100/385…”
Influential
Metadata
- Authors
- Huopio, H., Hakkarainen, H., Pääkkönen, M., Kuulasmaa, T., Voutilainen, R., Heinonen, S., & Cederberg, H.
- Venue
- BMC Pregnancy and Childbirth
- Published
- 2014-08-30
- Volume
- 14
- Issue
- 1
- Pages
- 296-296
- ISSN
- 1471-2393 (ISSN-L)
- OpenAlex
- W2063430126
- Cited by
- 38
- References
- 12
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term changes in glucose metabolism after gestational diabetes: a double cohort study. https://app.cochat.ai/papers/10.1186/1471-2393-14-296
- The paper
- Huopio, H., Hakkarainen, H., Pääkkönen, M., Kuulasmaa, T., Voutilainen, R., Heinonen, S., & Cederberg, H. (2014). Long-term changes in glucose metabolism after gestational diabetes: a double cohort study. BMC Pregnancy and Childbirth. https://doi.org/10.1186/1471-2393-14-296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.